Octreoscan Kit
NDC Package 69945-050-40

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Octreoscan (indium in -111 pentetreotide) kits is indium In-111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors. This formulation utilizes a kit delivery system. Marketed by Curium Us Llc, this product is identified by NDC 69945-050 and is authorized under FDA application NDA020314.

Identification & Billing

NDC Package Code
69945-050-40
Package Description
1 KIT in 1 BOX * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS
Product Code
69945-050
11-Digit Billing Format
69945005040

Clinical Specifications

Proprietary Name
Octreoscan
Non-Proprietary Name
Indium In -111 Pentetreotide
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Indium In-111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.

Regulatory & Marketing

Labeler Name
Curium Us Llc
Product Type
Human Prescription Drug
FDA Application #
NDA020314
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-14-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69945-050-40 identifies a specific commercial package of 1 kit in 1 box * 1 ml in 1 vial, glass * 1 ml in 1 vial, glass of Octreoscan, a human prescription drug labeled by Curium Us Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Curium Us Llc on October 14, 2015. The current certification is valid through December 31, 2026.

How is this Curium Us Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69945005040. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69945-050-40
11-Digit CMS (5-4-2)
69945-0050-40

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.